Hence, understanding the complex interplay between Hsps and cancer is an actively pursued area of research—Hsp-based approaches are considered to have a great contribution to oncoimmunology progress and to support the development of anticancer therapeutic regimens of higher efficacy and lower systemic toxicity. The gene discussed is HSP90B2P; the disease is cancer.